Jack W Callicutt - Net Worth and Insider Trading
Jack W Callicutt Net Worth
The estimated net worth of Jack W Callicutt is at least $8,756 dollars as of 2024-12-28. Jack W Callicutt is the CFO of Galectin Therapeutics Inc and owns about 7,614 shares of Galectin Therapeutics Inc (GALT) stock worth over $8,756. Details can be seen in Jack W Callicutt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jack W Callicutt has not made any transactions after 2024-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jack W Callicutt
Jack W Callicutt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jack W Callicutt owns 3 companies in total, including Galectin Therapeutics Inc (GALT) , Vystar Corp (VYST) , and VIA Pharmaceuticals Inc (VIAP) .
Click here to see the complete history of Jack W Callicutt’s form 4 insider trades.
Insider Ownership Summary of Jack W Callicutt
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GALT | Galectin Therapeutics Inc | 2020-01-09 | Chief Financial Officer |
VYST | Vystar Corp | 2011-03-14 | Chief Financial Officer |
VIAP | VIA Pharmaceuticals Inc | 2006-05-15 | VP-Finance&Admin & Chf Acct Off |
Jack W Callicutt Latest Holdings Summary
Jack W Callicutt currently owns a total of 1 stock. Jack W Callicutt owns 7,614 shares of Galectin Therapeutics Inc (GALT) as of December 23, 2024, with a value of $8,756.
Latest Holdings of Jack W Callicutt
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GALT | Galectin Therapeutics Inc | 2024-12-23 | 7,614 | 1.15 | 8,756 |
Holding Weightings of Jack W Callicutt
Jack W Callicutt Form 4 Trading Tracker
According to the SEC Form 4 filings, Jack W Callicutt has made a total of 1 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Galectin Therapeutics Inc is the sale of 40,000 shares on December 23, 2024, which brought Jack W Callicutt around $35,600.
Insider Trading History of Jack W Callicutt
- 1
Jack W Callicutt Trading Performance
GuruFocus tracks the stock performance after each of Jack W Callicutt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jack W Callicutt is 38.17%. GuruFocus also compares Jack W Callicutt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jack W Callicutt within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jack W Callicutt's insider trading performs compared to the benchmark.
Performance of Jack W Callicutt
Jack W Callicutt Ownership Network
Jack W Callicutt Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
Jack W Callicutt is the Chief Financial Officer of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, Jack W Callicutt made 1 insider transaction in Galectin Therapeutics Inc (GALT) with a net sale of 40,000. Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 16,867 shares made by Kary Eldred , a net purchase of 26,300 shares made by Kevin D Freeman , and a net purchase of 14,500 shares made by Zordani Richard A. Jr. .
In summary, during the past 3 months, insiders sold 109,654 shares of Galectin Therapeutics Inc (GALT) in total and bought 45,269 shares, with a net sale of 64,385 shares. During the past 18 months, 134,654 shares of Galectin Therapeutics Inc (GALT) were sold and 58,667 shares were bought by its insiders, resulting in a net sale of 75,987 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
Jack W Callicutt Mailing Address
Above is the net worth, insider trading, and ownership report for Jack W Callicutt. You might contact Jack W Callicutt via mailing address: 75 Fifth Street Nw Ste. 313, Atlanta Ga 30308.